{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:36:53Z","timestamp":1763534213721,"version":"build-2065373602"},"reference-count":39,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003605","name":"Korea International Cooperation Agency","doi-asserted-by":"publisher","award":["no number"],"award-info":[{"award-number":["no number"]}],"id":[{"id":"10.13039\/501100003605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Mumps remains endemic in Fiji, with 7802 cases reported between 2016 and 2018. The introduction of mumps vaccination has been discouraged due to perceptions of mumps as a self-limited disease and the perceived high cost of mumps vaccines. We estimated the benefits and costs of introducing a mumps vaccination program in Fiji. First, we estimated the burden of mumps and mumps-related complications in Fiji based on the reported cases in the Fiji National Notifiable Disease Surveillance System between 2016 and 2018. We then developed a static simulation model with stable mumps herd immunity after routine measles\u2013mumps\u2013rubella (MMR) vaccination. Finally, we compared the estimated economic burden of mumps with current MR vaccination and the assumptive burden of the stable-state simulation model after routine MMR vaccination. The benefit\u2013cost ratios (BCRs) were 2.65 from the taxpayer view and 3.00 from the societal view. A probabilistic sensitivity analysis indicated that the 1st and 99th percentiles of BCRs were 1.4 and 5.2 from the taxpayer\u2019s perspective and 1.5 and 6.1 from the societal perspective. From both the taxpayer and societal perspectives, the probability of BCRs greater than 1.0 was 100%. A routine MMR program has value for money from both the taxpayer and societal perspectives. MMR vaccination should be urgently introduced in Fiji.<\/jats:p>","DOI":"10.3390\/ijerph19031861","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T20:36:42Z","timestamp":1644266202000},"page":"1861","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An Economic Analysis of Mumps Vaccination in Fiji: Static Model Simulation of Routine Measles\u2013Mumps\u2013Rubella (MMR) Vaccination Instead of Current Measles\u2013Rubella (MR) Vaccination"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1631-3103","authenticated-orcid":false,"given":"Chunghyeon","family":"Oh","sequence":"first","affiliation":[{"name":"Department of Surgery, CWM Hospital, 1 Waimanu Road, Suva, Fiji"},{"name":"Fiji Office, Korea International Cooperation Agency, 91 Gordon St., Suva, Fiji"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7555-5666","authenticated-orcid":false,"given":"Eric","family":"Rafai","sequence":"additional","affiliation":[{"name":"Department for Research, Innovation, Data Analysis Management & Information Technology, Ministry of Health & Medical Services, 88 Amy Street, Suva, Fiji"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1516-4019","authenticated-orcid":false,"given":"Yinseo","family":"Cho","sequence":"additional","affiliation":[{"name":"West Africa Division, Korea International Cooperation Agency, Seongnam-si 13449, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damin","family":"Jun","sequence":"additional","affiliation":[{"name":"Performance Management Team, Korea International Cooperation Agency, Seongnam-si 13449, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1264-3313","authenticated-orcid":false,"given":"Seungman","family":"Cha","sequence":"additional","affiliation":[{"name":"Department of Global Development and Entrepreneurship, Graduate School of Global Development and Entrepreneurship, Handong Global University, Pohang 37554, Korea"},{"name":"Department of Disease Control, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Su, S.-B., Chang, H.-L., and Chen, K.-T. (2020). Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17051686"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/INF.0000000000001182","article-title":"Emerging Mumps Infection","volume":"35","author":"Rubin","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_3","unstructured":"WHO (2019). Global Immunization Coverage 2018, World Health Organization. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage."},{"key":"ref_4","unstructured":"WHO (2007). Mumps Virus Vaccine WHO Position Paper, World Health Organization."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1017\/S0950268800004672","article-title":"The pre-vaccination epidemiology of measles, mumps and rubella in Europe: Implications for modelling studies","volume":"125","author":"Edmunds","year":"2000","journal-title":"Epidemiol. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PHH.0000000000000962","article-title":"CDC Guidance for Use of a Third Dose of MMR Vaccine during Mumps Outbreaks","volume":"26","author":"Marlow","year":"2020","journal-title":"J. Public Health Manag. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1086\/520028","article-title":"Mumps Outbreaks in Canada and the United States: Time for New Thinking on Mumps Vaccines","volume":"45","author":"Peltola","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.4161\/hv.29484","article-title":"Outbreak of mumps in a school setting, United Kingdom, 2013","volume":"10","author":"Aasheim","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4149\/av_2013_02_91","article-title":"Overview of measles and mumps vaccine: Origin, present, and future of vaccine production","volume":"57","year":"2013","journal-title":"Acta Virol."},{"key":"ref_10","unstructured":"WHO (2018). Tenth Pacific Immunization Programme Managers Meeting, Nadi, Fiji, 30 July\u20133 August 2018: Meeting Report, WHO Regional Office for the Western Pacific."},{"key":"ref_11","unstructured":"Fiji MOHMS (2019). National Notifiable Disease Surveillance Bulletin. Mataika House 2016\u20132018."},{"key":"ref_12","unstructured":"Oh, C. (2019). Sudden Hearing Loss after Mumps Outbreak in CWM Hospital, in press."},{"key":"ref_13","unstructured":"Colonial War Memorial Hospital (2019). Time to Introduce Mumps Vaccination in Fiji, Colonial War Memorial Hospital. in press."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1080\/00016489.2017.1290826","article-title":"The clinical features and prognosis of mumps-associated hearing loss: A retrospective, multi-institutional investigation in Japan","volume":"137","author":"Morita","year":"2017","journal-title":"Acta Oto-Laryngol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/bmj.330.7500.1132","article-title":"Mumps and the UK epidemic 2005","volume":"330","author":"Gupta","year":"2005","journal-title":"BMJ"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/INF.0b013e31818a8ca8","article-title":"An office-based prospective study of deafness in mumps","volume":"28","author":"Hashimoto","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1016\/j.vaccine.2014.05.020","article-title":"Economic evaluation of vaccination programme of mumps vaccine to the birth cohort in Japan","volume":"32","author":"Hoshi","year":"2014","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1086\/378987","article-title":"An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States","volume":"189","author":"Zhou","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_19","first-page":"3","article-title":"Mumps and mumps vaccine: A global review","volume":"77","author":"Galazka","year":"1999","journal-title":"Bull. World Health Organ."},{"key":"ref_20","first-page":"8","article-title":"Fiji National Immunisation Coverage Survey\u20142013","volume":"3","author":"Devi","year":"2014","journal-title":"Fiji J. Public Health"},{"key":"ref_21","unstructured":"WHO\/UNICEF (2019). WHO and UNICEF Estimates of Immunization Coverage: 2019 Revision, United Nations\u2019 Children\u2019s Fund."},{"key":"ref_22","unstructured":"Irava, W., Pellny, M., and Khan, I. (2012). Costing Study of Selected Health Facilities in Fiji."},{"key":"ref_23","unstructured":"World Bank (2021). Inflation, Consumer Prices, Fiji, World Bank. Available online: https:\/\/data.worldbank.org\/indicator\/FP.CPI.TOTL.ZG?end=2017&locations=FJ&most_recent_year_desc=false&start=2012&view=chart."},{"key":"ref_24","unstructured":"World Bank (2021). Life Expectancy at Birth Total, Fiji, World Bank. Available online: https:\/\/data.worldbank.org\/indicator\/SP.DYN.LE00.IN?locations=FJ."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1086\/652770","article-title":"Guidance for isolation precautions for mumps in the United States: A review of the scientific basis for policy change","volume":"50","author":"Kutty","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7774\/cevr.2017.6.2.120","article-title":"Static model simulation for routine mumps vaccination in Japan: With a result of mumps-related complications in a Japanese community hospital","volume":"6","author":"Kitano","year":"2017","journal-title":"Clin. Exp. Vaccine Res."},{"key":"ref_27","unstructured":"Coopers, P.W. (2017). Fiji Budget Report 2017\u20132018, PricewaterhouseCoopers, a Fiji Partnership."},{"key":"ref_28","unstructured":"UNICEF (2021). Vaccine Price Data, United Nations Children\u2019s Fund. Available online: https:\/\/www.unicef.org\/supply\/vaccines-pricing-data?page=%2C1#listAnchor."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e04016","DOI":"10.1016\/j.heliyon.2020.e04016","article-title":"Estimation of the wastage rate of MMR and pentavalent vaccines in open and closed vials in three western provinces of Iran","volume":"6","author":"Zahraei","year":"2020","journal-title":"Heliyon"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.1016\/j.vaccine.2017.09.082","article-title":"Vaccine wastage in Nigeria: An assessment of wastage rates and related vaccinator knowledge, attitudes and practices","volume":"35","author":"Wallace","year":"2017","journal-title":"Vaccine"},{"key":"ref_31","unstructured":"Fiji Bureau of Statistics (2018). 2017 Population and Housing Census."},{"key":"ref_32","unstructured":"WHO (2021). Information Sheet Observed Rate of Vaccine Reactions Measles Mumps and Rubella Vaccines, World Health Organization. Available online: https:\/\/www.who.int\/vaccine_safety\/initiative\/tools\/MMR_vaccine_rates_information_sheet.pdf."},{"key":"ref_33","first-page":"362","article-title":"A benefit-cost analysis of mumps vaccine","volume":"136","author":"Koplan","year":"1982","journal-title":"Am. J. Dis. Child."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00006454-198911000-00004","article-title":"Clinical and epidemiologic features of mumps meningoencephalitis and possible vaccine-related disease","volume":"8","author":"McDonald","year":"1989","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_35","first-page":"74","article-title":"Cost-benefit analysis of routine mumps and rubella vaccination for Israeli infants","volume":"26","author":"Berger","year":"1990","journal-title":"Isr. J. Med. Sci."},{"key":"ref_36","unstructured":"Ministry of HEALTH & Medical Service (2021, December 07). Budget 2018\u20132019 Highlights, Available online: https:\/\/www.health.gov.fj\/wp-content\/uploads\/2018\/12\/12-July.pdf."},{"key":"ref_37","unstructured":"The Pacific Community (2018). 6th Head of Health Meeting Report, The Pacific Community. Available online: https:\/\/www.spc.int\/sites\/default\/files\/eventfiles\/2019-03\/6th_HOH_Fiji%202018%20Meeting%20Report%20and%20annexes.pdf."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/mdh.2020.19","article-title":"Reasonable Grounds? The Delayed Introduction of MMR Vaccine in Denmark and The Netherlands, 1977\u20131987","volume":"64","author":"Berg","year":"2020","journal-title":"Med. Hist."},{"key":"ref_39","unstructured":"WHO (2020). Immunization Agenda 2030: A Global Strategy to Leave No One Behind, World Health Organization."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/3\/1861\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:15:36Z","timestamp":1760134536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/3\/1861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["ijerph19031861"],"URL":"https:\/\/doi.org\/10.3390\/ijerph19031861","relation":{},"ISSN":["1660-4601"],"issn-type":[{"type":"electronic","value":"1660-4601"}],"subject":[],"published":{"date-parts":[[2022,2,7]]}}}